Vertex CEO Kewalramani nabs more than $15M in 2021 pay, rivaling some male Big Pharma peers

In her first full year at the top of cystic fibrosis juggernaut Vertex Pharmaceuticals, CEO Reshma Kewalramani has collected a pay package that rivals compensation at some Big Pharma companies.

Kewalramani’s 2021 salary clocked in at around $1.22 million, while the CEO collected more than $3 million in cash incentive pay, a new proxy filing shows. Stock awards made the biggest contribution to Kewalramani’s haul at nearly $11 million, more than double the amount she took home in that category in 2020. Meanwhile, she scored another $35,764 in “other compensation.”